BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19604112)

  • 1. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma.
    Cosan D; Kurt E; Kurt H; Degirmenci I; Kuçukarabaci B; Metintas M; Kucuk MU; Gunes HV; Colak E
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):543-6. PubMed ID: 19604112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome.
    Kilicci C; Bayram B; Ozkurt M; Onlu H; Erkasap N; Mutlu F
    Genet Test Mol Biomarkers; 2011; 15(7-8):565-7. PubMed ID: 21413876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism is associated with hypertensive patients in the Turkish population.
    Gunes HV; Cosan DT; Ata N; Birdane A; Ustuner MC; Dikmen M; Bayram B; Degirmenci I
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):303-5. PubMed ID: 20392162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.
    Ozbek OY; Ataç FB; Ogus E; Ozbek N
    Allergy Asthma Proc; 2009; 30(1):41-6. PubMed ID: 19063817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritis.
    Bayram B; Sayin E; Erkasap N; Onlü H; Ozkurt M; Sahin F; Türkoğlu Z
    Rheumatol Int; 2012 Jan; 32(1):259-62. PubMed ID: 21240498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C; Ozdemir Koroglu Z; Kurt H; Yanas M; Colak E; Degirmenci I; Gunes HV
    J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.
    Bayramoglu A; Gunes HV; Metintas M; Degirmenci I; Guler HI; Ustuner C; Musmul A
    Genet Test Mol Biomarkers; 2014 Aug; 18(8):587-90. PubMed ID: 24955483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.
    Bora E; Soylar R; Arıkan-Ayyıldız Z; Uzuner N; Giray-Bozkaya Ö; Erçal D; Karaman Ö; Ülgenalp A
    Allergol Immunopathol (Madr); 2013; 41(1):11-6. PubMed ID: 22361338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of -675 4 g/5 G SERPINE1 and C-159T CD14 polymorphisms in house dust mite-allergic asthma patients.
    Kowal K; Bodzenta-Lukaszyk A; Pampuch A; Szmitkowski M; Zukowski S; Donati MB; Iacoviello L
    J Investig Allergol Clin Immunol; 2008; 18(4):284-92. PubMed ID: 18714537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome.
    Luo Y; Wang C; Tu H
    Mol Med Rep; 2014 Mar; 9(3):894-8. PubMed ID: 24435552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism frequency and plasma PAI-1 enzyme activity in patients with acute stroke.
    Kucukarabaci B; Gunes HV; Ozdemir G; Cosan D; Ozbabalik D; Dikmen M; Degirmenci I
    Genet Test; 2008 Sep; 12(3):443-51. PubMed ID: 18662099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor I 4G/5G polymorphism in neonatal respiratory distress syndrome.
    Armangil D; Yurdakök M; Okur H; Gürgey A
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):352-7. PubMed ID: 20460339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism 4G/5G of the plasminogen activator inhibitor 1 gene as a risk factor for the development of allergic rhinitis symptoms in patients with asthma.
    Lampalo M; Jukic I; Bingulac-Popovic J; Marunica I; Petlevski R; Pavlisa G; Popovic-Grle S
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2613-2619. PubMed ID: 28258374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
    Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients.
    Pampuch A; Kowal K; Bodzenta-Lukaszyk A; Di Castelnuovo A; Chyczewski L; Donati MB; Iacoviello L
    Allergy; 2006 Feb; 61(2):234-8. PubMed ID: 16409202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A.
    Akar N; Yilmaz E; Akar E; Avcu F; Yalçin A; Cin S
    Thromb Res; 2000 Feb; 97(4):227-30. PubMed ID: 10674409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
    Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.